Introduction: Human papillomavirus (HPV) infection is the most widespread sexually transmitted infection in the world. Today, there is growing evidence that HPV can be transmitted early in life, and one potential route is mother-to-child transmission. Data on this route of HPV transmission are scarce in Africa and particularly in Burkina Faso, where no data on the subject are yet available. The aim of our study was to estimate the rate of mother-to-child transmission of HPV infection and to identify circulating genotypes. Methodology: Cervico-uterine samples were collected from 100 full-term pregnant women and, buccal samples were obtained from their newborns at Hopital Saint Camille de Ouagadougou (HOSCO) by the specialist physician. HPV DNA amplification and genotyping were performed by PCR followed by hybridization using the HPV Direct Flow Chips kit, detecting 36 genotypes including 18 high-risk and 18 low-risk. Results: The prevalence of HPV in newborns was 8% (8/100). Six (6) HPV-positive neonates had HPV-positive mothers, while 2 HPV-positive neonates had HPV-negative mothers. The vertical transmission rate was 26.09% (6/23). Mother-newborn genotypes were concordant. However, the genotype profile of the newborns was more restricted than that of the mothers. Conclusion: HPV DNA was found in 8% of newborns in our study. The genotype profile of the mother-newborn pair was concordant. Asymptomatic HPV infection in a pregnant woman could constitute a risk factor for vertical transmission.
References
[1]
WHO (2022) Sexually Transmitted Infections (STIs).
https://www.who.int/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)
[2]
Chesson, H.W., Dunne, E.F., Hariri, S. and Markowitz, L.E. (2014) The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sexually Transmitted Diseases, 41, 660-664.
https://doi.org/10.1097/OLQ.0000000000000193
[3]
Doh, G., Mkong, E., Ikomey, G.M., Obasa, A.E., Mesembe, M., Fokunang, C. and Jacobs, G.B. (2021) Preinvasive Cervical Lesions and High Prevalence of Human Papilloma Virus among Pregnant Women in Cameroon. Germs, 11, 78-87.
https://doi.org/10.18683/germs.2021.1243
[4]
Martínez-Leal, B., Alvarez-Banderas, K.I., Sánchez-Dávila, H., Dávila-Rodríguez, M.I. and Cortés-Gutiérrez, E.I. (2020) Human Papillomavirus as a Single Infection in Pregnant Women from Northeastern Mexico: Cross-Sectional Study. International Journal of Reproductive BioMedicine, 18, 129-134.
https://doi.org/10.18502/ijrm.v18i2.6433
[5]
Niyibizi, J., Zanré, N., Mayrand, M.H. and Trottier, H. (2017) The Association between Adverse Pregnancy Outcomes and Maternal Human Papillomavirus Infection: A Systematic Review Protocol. Systematic Reviews, 6, Article No. 53.
https://doi.org/10.1186/s13643-017-0443-5
[6]
Skinner, S.R., Wheeler, C.M., Romanowski, B., Castellsagué, X., Lazcano-Ponce, E., Del Rosario-Raymundo, M.R., Vallejos, C., Minkina, G., Pereira Da Silva, D., Mcneil, S., Prilepskaya, V., Gogotadze, I., Money, D., Garland, S.M., Romanenko, V., Harper, D.M., Levin, M.J., Chatterjee, A., Geeraerts, B., Struyf, F., Dubin, G., Bozonnat, M.C., Rosillon, D. and Baril, L. (2016) Progression of HPV Infection to Detectable Cervical Lesions or Clearance in Adult Women: Analysis of the Control Arm of the VIVIANE Study. International Journal of Cancer, 138, 2428-2438.
https://doi.org/10.1002/ijc.29971
[7]
Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J., Gómez, D., Munoz, J., Bosch, F. and De Sanjosé, S. (2022) Human Papillomavirus and Related Diseases in Africa. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre) Human Papillomavirus and Related Diseases in Africa. Summary Report 2 February 2022.
[8]
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
[9]
Arbyn, M., Weiderpass, E., Bruni, L., De Sanjosé, S., Saraiya, M., Ferlay, J. and Bray, F. (2020) Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis. The Lancet Global Health, 8, e191-e203.
https://doi.org/10.1016/S2214-109X(19)30482-6
[10]
Bosch, F.X., Broker, T.R., Forman, D., Moscicki, A.B., Gillison, M.L., Doorbar, J., Stern, P.L., Stanley, M., Arbyn, M., Poljak, M., Cuzick, J., Castle, P.E., Schiller, J.T., Markowitz, L.E., Fisher, W.A., Canfell, K., Denny, L.A., Franco, E.L., Steben, M., Kane, M.A., Schiffman, M., Meijer, C.J., Sankaranarayanan, R., Castellsagué, X., Kim, J.J., Brotons, M., Alemany, L., Albero, G., Diaz, M. and De Sanjosé, S. (2013) Comprehensive Control of Human Papillomavirus Infections and Related Diseases. Vaccine, 31, I1-I31. https://doi.org/10.1016/j.vaccine.2013.07.026
[11]
Gutiérrez-Pascual, M., Vicente-Martín, F.J. and López-Estebaranz, J.L. (2012) Lichen Sclerosus and Squamouscellcarcinoma. Actas Dermo-Sifiliográficas, 103, 21-28.
https://doi.org/10.1016/j.adengl.2011.05.004
[12]
Ilboudo, M., Zohoncon, T.M., Traore, I.M.A., Traore, E.M.A., Kande, A., Obiri-Yeboah, D., Djigma, F.W., Gyebre, Y.M.C. and Simpore, J. (2019) Implication of Low Risk Human Papillomaviruses, HPV6 and HPV11 in Laryngeal Papillomatosis in Burkina Faso. American Journal of Otolaryngology, 40, 368-371.
https://doi.org/10.1016/j.amjoto.2019.02.003
[13]
Skoczyński, M., Gozdzicka-Józefiak, A. and Kwasniewska, A. (2019) Co-Occurrence of Human Papillomavirus (HPV) in Newborns and Their Parents. BMC Infectious Diseases, 19, Article No. 930. https://doi.org/10.1186/s12879-019-4503-4
[14]
Sabeena, S., Bhat, P., Kamath, V. and Arunkumar, G. (2017) Possible Non-Sexual Modes of Transmission of Human Papilloma Virus. Journal of Obstetrics and Gynaecology Research, 43, 429-435. https://doi.org/10.1111/jog.13248
[15]
Merckx, M., Liesbeth, W.V., Arbyn, M., Meys, J., Weyers, S., Temmerman, M. and Vanden Broeck, D. (2013) Transmission of Carcinogenic Human Papillomavirus Types from Mother to Child: A Meta-Analysis of Published Studies. European Journal of Cancer Prevention, 22, 277-285. https://doi.org/10.1097/CEJ.0b013e3283592c46
[16]
Zohoncon, T., Djigma, W.F., Ouattara, A., Traore, I.M.A., Ouédraogo, R.A.E.E., Bado, P., Ouedraogo, T.C., Diarra, B., Ilboudo, M., Capo-Chichi, C.D., Obiri-Yeboah, D., Karou, S., Nayama, M., Horo, A., Kouakou, K.P., Gomina, M., Ouattara, S., Sanni, A., Simon, A., Ouédraogo, C. and Simpore, J. (2020) Mapping of Fourteen High-Risk Human Papillomavirus Genotypes by Molecular Detection in Sexually Active Women in the West African Sub-Region. Journal of Genetics and Molecular Biology, 12, 11-21.
[17]
Kabre, K.M., Ouermi, D., Zohoncon, T.M., Traore, F.P.W., Gnoumou, O.P.P., Ouedraogo, R.A., Yonli, A.T., Bado, P., Ouedraogo, P., Ouedraogo, T.C., Yelemkoure, T.E., Kuassi-Kpede, P.A., Obiri-Yeboah, D., Ouedraogo, C.M.R. and Simpore, J. (2022) Molecular Epidemiology of Human Papillomavirus in Pregnant Women in Burkina Faso. Biomolecular Concepts, 13, 334-340.
https://doi.org/10.1515/bmc-2022-0026
[18]
Zohoncon, T.M., Rogomenoma Alice, O., Florencia Wendkuuni, D., Lassina, T., Teega-Wendé Clarisse, O., Maimouna, I., Regine, I., Catherine, S., Sindimalgdé Patricia, G., Sessi Frida, T., Mah Alima Esther, T., Prosper, B., Ali, K., Cyrille, B., Abdoul Karim, O., Ina Marie Angèle, T., Djeneba, O., Tani, S., Albert Théophane, Y., Wendyam Marie Christelle, N., Dorcas, O.-Y., Yvette Marie Chantal, G., Olga Mélanie, L., Charlemagne Marie Ragnag-Newende, O. and Jacques, S. (2022) Molecular Epidemiology of High-Risk Human Papillomavirus Infection in Burkina Faso. In: Metin, B. and Rajamanickam, R., Eds., Molecular Mechanisms in Cancer, IntechOpen, Rijeka, Ch. 8.
[19]
Tovo, S.F., Zohoncon, T.M., Dabiré, A.M., Ilboudo, R., Tiemtoré, R.Y., Obiri-Yeboah, D., Yonli, A.T., Dovo, E.E., Ouédraogo, R.A., Ouattara, A.K., Sorgho, P.A., Ouermi, D., Djigma, F.W., Ouédraogo, C., Sangaré, L. and Simpore, J. (2021) Molecular Epidemiology of Human Papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among Female Sex Workers in Burkina Faso: Prevalence, Coinfections and Drug Resistance Genes. Tropical Medicine and Infectious Disease, 6, Article No. 90. https://doi.org/10.3390/tropicalmed6020090
[20]
Ouedraogo, R.A., Zohoncon, T.M., Traore, I.M.A., Ouattara, A.K., Guigma, S.P., Djigma, F.W., Obiri-Yeboah, D., Ouedraogo, C. and Simpore, J. (2020) Genotypic Distribution of Human Oncogenic Papillomaviruses in Sexually Active Women in Burkina Faso: Central, Central-Eastern and Hauts-Bassins Regions. Biomolecular Concepts, 11, 125-136. https://doi.org/10.1515/bmc-2020-0011
[21]
Zohoncon, T.M., Bado, P., Ouermi, D., Traore, M.A.E., Ouattara, S., Djigma, F., Traore, I., Yonli, A., Obiri-Yeboah, D., Ouédraogo, C., Simon, A., Lompo, O. and Simpore, J. (2016) Molecular Characterization of High-Risk Human Papillomavirus Genotypes Involved in Invasive Cervical Cancer from Formalin-Fixed, Paraffin-Embedded Tissues in Ouagadougou, Burkina Faso. International Journal of Current Research, 8, 39314-39318.
[22]
Traore, I.M.A., Zohoncon, T.M., Ndo, O., Djigma, F.W., Obiri-Yeboah, D., Compaore, T.R., Guigma, S.P., Yonli, A.T., Traore, G., Ouedraogo, P., Ouedraogo, C.M.R., Traore, Y. and Simpore, J. (2016) Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso. Pakistan Journal of Biological Sciences, 19, 306-311.
https://doi.org/10.3923/pjbs.2016.306.311
[23]
Ouédraogo, C.M., Rahimy, R.M., Zohoncon, T.M., Djigma, F.W., Yonli, A.T., Ouermi, D., Sanni, A., Lankoande, J. and Simpore, J. (2015) Epidemiology and Characterization of High-Risk Genotypes of Human Papillomavirus in a Population of Sexually Active Adolescents in Ouagadougou. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 44, 715-722. https://doi.org/10.1016/j.jgyn.2014.12.021
[24]
Djigma, F.W., Ouédraogo, C., Karou, D.S., Sagna, T., Bisseye, C., Zeba, M., Ouermi, D., Gnoula, C., Pietra, V., Ghilat-Avoid-Belem, N.W., Sanogo, K., Sempore, J., Pignatelli, S., Ferri, A.M., Nikiema, J.B. and Simpore, J. (2011) Prevalence and Genotype Characterization of Human Papillomaviruses among HIV-Seropositive in Ouagadougou, Burkina Faso. Acta Tropica, 117, 202-206.
https://doi.org/10.1016/j.actatropica.2010.12.007
[25]
Luo, D., Peng, M., Wei, X., Pan, D., Xue, H., Xu, Y. and Dong, B. (2021) Prevalence of Human Papillomavirus and Genotype Distribution in Pregnant and Non-Pregnant Women in China. Risk Management and Healthcare Policy, 14, 3147-3157.
https://doi.org/10.2147/RMHP.S288838
[26]
Salcedo, M.M., Damin, A.P., Agnes, G., Pessini, S.A., Beitune, P.E., Alexandre, C.O., Schmeler, K.M. and Da Silveira, G.P. (2015) Prevalence of Human Papillomavirus Infection in Pregnant Versus Non-Pregnant Women in Brazil. Archives of Gynecology and Obstetrics, 292, 1273-1278. https://doi.org/10.1007/s00404-015-3752-8
[27]
Liu, P., Xu, L., Sun, Y. and Wang, Z. (2014) The Prevalence and Risk of Human Papillomavirus Infection in Pregnant Women. Epidemiology & Infection, 142, 1567-1578. https://doi.org/10.1017/S0950268814000636
[28]
Schulze, M.H., Volker, F.M., Lugert, R., Cooper, P., Hasenclever, K., Groß, U., Pfister, H. and Silling, S. (2016) High Prevalence of Human Papillomaviruses in Ghanaian Pregnant Women. Medical Microbiology and Immunology, 205, 595-602.
https://doi.org/10.1007/s00430-016-0475-9
[29]
Kwon, M.J., Roh, K.H., Park, H. and Woo, H.Y. (2014) Comparison of the Anyplex II HPV28 Assay with the Hybrid Capture 2 Assay for the Detection of HPV Infection. Journal of Clinical Virology, 59, 246-249.
https://doi.org/10.1016/j.jcv.2014.01.015
[30]
Hahn, H.S., Kee, M.K., Kim, H.J., Kim, M.Y., Kang, Y.S., Park, J.S. and Kim, T.J. (2013) Distribution of Maternal and Infant Human Papillomavirus: Risk Factors Associated with Vertical Transmission. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 169, 202-206.
https://doi.org/10.1016/j.ejogrb.2013.02.024
[31]
Trottier, H., Mayrand, M.H., Coutlée, F., Monnier, P., Laporte, L., Niyibizi, J., Carceller, A.M., Fraser, W.D., Brassard, P., Lacroix, J., Francoeur, D., Bédard, M.J., Girard, I. and Audibert, F. (2016) Human Papillomavirus (HPV) Perinatal Transmission and Risk of HPV Persistence among Children: Design, Methods and Preliminary Results of the HERITAGE Study. Papillomavirus Research, 2, 145-152.
https://doi.org/10.1016/j.pvr.2016.07.001
[32]
Skoczyński, M., Gozdzicka-Józefiak, A. and Kwasniewska, A. (2015) The Prevalence of Human Papillomavirus between the Neonates and Their Mothers. BioMed Research International, 2015, Article ID: 126417.
https://doi.org/10.1155/2015/126417
[33]
Rice, P.S., Cason, J., Best, J.M. and Banatvala, J.E. (1999) High Risk Genital Papillomavirus Infections Are Spread Vertically. Reviews in Medical Virology, 9, 15-21.
https://doi.org/10.1002/(SICI)1099-1654(199901/03)9:1<15::AID-RMV232>3.0.CO;2-Q
[34]
Tenti, P., Zappatore, R., Migliora, P., Spinillo, A., Belloni, C. and Carnevali, L. (1999) Perinatal Transmission of Human Papillomavirus from Gravidas with Latent Infections. Obstetrics & Gynecology, 93, 475-479.
https://doi.org/10.1097/00006250-199904000-00001
[35]
Skoczyński, M., Gozdzicka-Józefiak, A. and Kwasniewska, A. (2014) Risk Factors of the Vertical Transmission of Human Papilloma Virus in Newborns from Singleton Pregnancy-Preliminary Report. The Journal of Maternal-Fetal & Neonatal Medicine, 27, 239-242. https://doi.org/10.3109/14767058.2013.807238
[36]
Castellsagué, X., Drudis, T., Canadas, M.P., Goncé, A., Ros, R., Pérez, J.M., Quintana, M.J., Munoz, J., Albero, G., De Sanjosé, S. and Bosch, F.X. (2009) Human Papillomavirus (HPV) Infection in Pregnant Women and Mother-to-Child Transmission of Genital HPV Genotypes: A Prospective Study in Spain. BMC Infectious Diseases, 9, Article No. 74. https://doi.org/10.1186/1471-2334-9-74
[37]
Lee, S.M., Park, J.S., Norwitz, E.R., Koo, J.N., Oh, I.H., Park, J.W., Kim, S.M., Kim, Y.H., Park, C.W. and Song, Y.S. (2013) Risk of Vertical Transmission of Human Papillomavirus throughout Pregnancy: A Prospective Study. PLOS ONE, 8, e66368.
https://doi.org/10.1371/journal.pone.0066368
